We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-14.17%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$148M
AUM Growth
-$5.35M
Cap. Flow
+$5.43M
Cap. Flow %
3.67%
Top 10 Hldgs %
28.04%
Holding
1,105
New
171
Increased
281
Reduced
187
Closed
105

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$1.6M
2
TSM icon
TSMC
TSM
+$1.57M
3
AMZN icon
Amazon
AMZN
+$1.55M
4
SAP icon
SAP
SAP
+$1.19M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.02M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$2.27M
2
CVX icon
Chevron
CVX
+$1.93M
3
FLO icon
Flowers Foods
FLO
+$1.68M
4
PANW icon
Palo Alto Networks
PANW
+$1.63M
5
CBRL icon
Cracker Barrel
CBRL
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 31.57%
2 Healthcare 15.81%
3 Financials 9.06%
4 Consumer Staples 6.94%
5 Consumer Discretionary 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRI icon
501
Thomson Reuters
TRI
$39.4B
$8K 0.01%
114
-10
-8% -$779
XSLV icon
502
Invesco S&P SmallCap Low Volatility ETF
XSLV
$249M
$8K 0.01%
225
ZBRA icon
503
Zebra Technologies
ZBRA
$12.4B
$8K 0.01%
36
-7
-16% -$1.57K
MMP
504
DELISTED
Magellan Midstream Partners, L.P.
MMP
$8K 0.01%
+200
New +$10.7K
CLR
505
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$8K 0.01%
461
IBDN
506
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$8K 0.01%
300
AMP icon
507
Ameriprise Financial
AMP
$46.8B
$7K ﹤0.01%
65
-23
-26% -$3.41K
BIO icon
508
Bio-Rad Laboratories Class A
BIO
$8.42B
$7K ﹤0.01%
17
-2
-11% -$735
BKNG icon
509
Booking.com
BKNG
$138B
$7K ﹤0.01%
125
-75
-38% -$5.26K
CBOE icon
510
Cboe Global Markets
CBOE
$29.8B
$7K ﹤0.01%
66
CHE icon
511
Chemed
CHE
$6.78B
$7K ﹤0.01%
18
+9
+100% +$4.02K
CNC icon
512
Centene
CNC
$31.3B
$7K ﹤0.01%
+98
New +$5.95K
DEA
513
Easterly Government Properties
DEA
$1.18B
$7K ﹤0.01%
102
-9
-8% -$539
DOV icon
514
Dover
DOV
$27.2B
$7K ﹤0.01%
79
-21
-21% -$2.23K
ETN icon
515
Eaton
ETN
$157B
$7K ﹤0.01%
84
+30
+56% +$2.75K
FXI icon
516
iShares China Large-Cap ETF
FXI
$4.31B
$7K ﹤0.01%
180
HUBS icon
517
HubSpot
HUBS
$10.5B
$7K ﹤0.01%
44
+13
+42% +$2.16K
IAGG icon
518
iShares Core International Aggregate Bond Fund
IAGG
$10.6B
$7K ﹤0.01%
+134
New +$7.41K
IVE icon
519
iShares S&P 500 Value ETF
IVE
$48.9B
$7K ﹤0.01%
+70
New +$8.33K
IYT icon
520
iShares US Transportation ETF
IYT
$2.33B
$7K ﹤0.01%
180
MFC icon
521
Manulife Financial
MFC
$72.6B
$7K ﹤0.01%
+527
New +$9.16K
MUR icon
522
Murphy Oil
MUR
$5.58B
$7K ﹤0.01%
575
PCEF icon
523
Invesco CEF Income Composite ETF
PCEF
$812M
$7K ﹤0.01%
392
+100
+34% +$2.17K
PUK icon
524
Prudential
PUK
$36.5B
$7K ﹤0.01%
250
-184
-42% -$5.86K
SABR icon
525
Sabre
SABR
$656M
$7K ﹤0.01%
957

Similar funds

Front Row Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Front Row Advisors held 1,105 positions worth $148M, down 3.5% from $153M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Front Row Advisors deployed $5.43M of net new capital in Q1 2020, opening 171 new positions and adding to 281 existing holdings. Its largest new stake was Intuitive Surgical: 5,550 shares worth $945K.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Cisco, an estimated $2.27M trimmed.

  • Front Row Advisors's largest Q1 2020 buy was Intuitive Surgical: 5,550 shares worth $945K.
  • Front Row Advisors added most to Synopsys in Q1 2020, an estimated $1.6M increase.
  • Front Row Advisors's biggest Q1 2020 reduction was Cisco, cutting an estimated $2.27M.
  • Front Row Advisors fully exited Palo Alto Networks in Q1 2020, selling an estimated $1.63M.
  • Front Row Advisors's ten largest holdings make up 28% of its $148M portfolio in Q1 2020.
  • Front Row Advisors opened 171 new positions and closed 105 in Q1 2020.
  • Front Row Advisors's portfolio value fell 3.5% quarter-over-quarter to $148M.

Based on Front Row Advisors's 13F filing for Q1 2020, filed 8 May 2020.